Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-30

Clinical Trial Update: Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gabapentin and lamotrigine versus carbamazepine for seizure control in the elderly, focusing on side-effect profile and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • Gabapentin (Gabapentin)
  • Lamotrigine (lamotrigine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Seizures | Phase 3 | Status: COMPLETED